Page last updated: 2024-08-25

zoledronic acid and Granuloma, Plasma Cell, Orbital

zoledronic acid has been researched along with Granuloma, Plasma Cell, Orbital in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ajlan, RS; Champion, M; Herrera, I; Kam, Y; Whittaker, TJ1
Arroyo, JG; Freitag, SK; Lefebvre, DR; Mandeville, JT; Torun, N; Yonekawa, Y1
Albiani, DA; Anderson, DP; Barton, JJ; Seth, A1
Bedrossian, EH; Peterson, JD1
Newman, SA; Phillips, PM1

Reviews

2 review(s) available for zoledronic acid and Granuloma, Plasma Cell, Orbital

ArticleYear
A Case Series and Review of Bisphosphonate-associated Orbital Inflammation.
    Ocular immunology and inflammation, 2016, Volume: 24, Issue:2

    Topics: Aged; Alendronate; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Magnetic Resonance Imaging; Male; Middle Aged; Orbital Cellulitis; Orbital Pseudotumor; Remission, Spontaneous; Retrospective Studies; Zoledronic Acid

2016
Bisphosphonate-associated orbital inflammation--a case report and review.
    Orbit (Amsterdam, Netherlands), 2012, Volume: 31, Issue:2

    Topics: Bone Density Conservation Agents; Diphosphonates; Edema; Eye Pain; Eyelid Diseases; Female; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Orbital Pseudotumor; Osteoporosis, Postmenopausal; Tomography, X-Ray Computed; Uveitis, Anterior; Vision Disorders; Zoledronic Acid

2012

Other Studies

3 other study(ies) available for zoledronic acid and Granuloma, Plasma Cell, Orbital

ArticleYear
Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy.
    BMC ophthalmology, 2019, Feb-14, Volume: 19, Issue:1

    Topics: Administration, Oral; Bone Density Conservation Agents; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Middle Aged; Orbital Pseudotumor; Osteoporosis, Postmenopausal; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisone; Sjogren's Syndrome; Zoledronic Acid

2019
Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2009, Volume: 44, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Diphosphonates; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Ibuprofen; Imidazoles; Magnetic Resonance Imaging; Male; Optic Neuropathy, Ischemic; Orbital Pseudotumor; Prednisone; Prostatic Neoplasms; Zoledronic Acid

2009
Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:1

    Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Glucocorticoids; Humans; Imidazoles; Infusions, Intravenous; Kidney Neoplasms; Male; Middle Aged; Orbital Pseudotumor; Prednisone; Tomography, X-Ray Computed; Zoledronic Acid

2008